Drawing for CERBIOS

USPTO serial 79075666

CERBIOS

Reviewed by CopyMark Law Group

Reg. 3832188Status 707Registered
Filing date
Status date
Registration date
Aug 10, 2010
Examiner
SCHRODY, ALLISON PAIGE
Law office
—

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CERBIOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa A. Iverson

Lisa A. Iverson Iverson IP3642 N. Racine AveChicago, IL 60613UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, namely, chemical preparations for scientific purposes, cultures of microorganisms other than for medical and veterinary use, protein arrays and nucleotide arrays for scientific and medical researchACTIVE—
005[ Pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; cultures of microorganisms for pharmaceutical, medical and veterinary use ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 16, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 2, 2022INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Mar 23, 2022INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 23, 2022INPCINVALIDATION PROCESSED—
Nov 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 9, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 9, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 9, 202171.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Mar 9, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 9, 2021ES71TEAS SECTION 71 RECEIVED—
Feb 27, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 5, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 10, 2019REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Aug 1, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 29, 2016NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Aug 29, 2016C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 29, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 20, 2016ES75TEAS SECTION 71 & 15 RECEIVED—
Apr 28, 2016ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 21, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 24, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 24, 2010FIMPFINAL DISPOSITION PROCESSED—
Nov 10, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 10, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 25, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 19, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 19, 2010ALIEASSIGNED TO LIE—
Apr 2, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2010ALIEASSIGNED TO LIE—
Feb 19, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2010RFNTREFUSAL PROCESSED BY IB—
Dec 23, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 23, 2009RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 19, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 18, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2009DOCKASSIGNED TO EXAMINER—
Dec 15, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance